These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 19861513)
1. Association between lifestyle factors and CpG island methylation in a cancer-free population. Brait M; Ford JG; Papaiahgari S; Garza MA; Lee JI; Loyo M; Maldonado L; Begum S; McCaffrey L; Howerton M; Sidransky D; Emerson MR; Ahmed S; Williams CD; Hoque MO Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2984-91. PubMed ID: 19861513 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549 [TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364 [TBL] [Abstract][Full Text] [Related]
4. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028 [TBL] [Abstract][Full Text] [Related]
5. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Krassenstein R; Sauter E; Dulaimi E; Battagli C; Ehya H; Klein-Szanto A; Cairns P Clin Cancer Res; 2004 Jan; 10(1 Pt 1):28-32. PubMed ID: 14734448 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiles of lung tumors. Toyooka S; Toyooka KO; Maruyama R; Virmani AK; Girard L; Miyajima K; Harada K; Ariyoshi Y; Takahashi T; Sugio K; Brambilla E; Gilcrease M; Minna JD; Gazdar AF Mol Cancer Ther; 2001 Nov; 1(1):61-7. PubMed ID: 12467239 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
8. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Gutiérrez MI; Siraj AK; Khaled H; Koon N; El-Rifai W; Bhatia K Mod Pathol; 2004 Oct; 17(10):1268-74. PubMed ID: 15154012 [TBL] [Abstract][Full Text] [Related]
9. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. Su PF; Huang WL; Wu HT; Wu CH; Liu TY; Kao SY Oral Oncol; 2010 Oct; 46(10):734-9. PubMed ID: 20729138 [TBL] [Abstract][Full Text] [Related]
10. Altered methylation of multiple genes in carcinogenesis of the prostate. Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
13. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406 [TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum. Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078 [TBL] [Abstract][Full Text] [Related]
15. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522 [TBL] [Abstract][Full Text] [Related]
16. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557 [TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients. Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385 [TBL] [Abstract][Full Text] [Related]
20. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues. Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]